[{"id":"f9042111-c761-43e5-863e-eef97d84106a","acronym":"","url":"https://clinicaltrials.gov/study/NCT00660218","created_at":"2021-01-18T02:27:38.711Z","updated_at":"2024-07-02T16:36:21.001Z","phase":"Phase 1/2","brief_title":"A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer","source_id_and_acronym":"NCT00660218","lead_sponsor":"State University of New York - Upstate Medical University","biomarkers":" ER","pipe":" | ","alterations":" ER expression","tags":["ER"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ER expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Erbitux (cetuximab) • Opaxio (paclitaxel poliglumex)"],"overall_status":"Completed","enrollment":" Enrollment 53","initiation":"Initiation: 03/01/2008","start_date":" 03/01/2008","primary_txt":" Primary completion: 12/01/2016","primary_completion_date":" 12/01/2016","study_txt":" Completion: 04/01/2017","study_completion_date":" 04/01/2017","last_update_posted":"2021-11-08"}]